News

Publication: The Use of Cell Microarray Technology for Rapid Identification of Therapeutic SARS-CoV-2 Protein Targets

The Use of Cell Microarray Technology for Rapid Identification of Therapeutic SARS-CoV-2 Protein Targets

A high throughput screening library approach was used to detect binding interactions of SARS-CoV-2 proteins, confirming a number of previously known receptors as well as the discovery of three novel receptors: NID1, CNTN1, and APOA4. With this knowledge, we may further understand disease pathogenesis of COVID-19 patients and how infection by SARS-CoV-2 may lead to failure of specific organs or virulence in different ethnicities. Importantly, we illustrate a methodology that can be used for rapid and unbiased identification of cell surface receptors to support drug screening and drug repurposing approaches for this and future pandemics.

Full-length SARS-CoV-2 spike trimer proteins were screened for binding to 5845 human HEK293 cell-expressed monomeric or heterodimeric human plasma membrane proteins and cell-surface tethered human secreted proteins using the Retrogenix cell microarray technology. This physiologically relevant system allows even low affinity interactions with the viral spike protein to be detected with a high degree of sensitivity and specificity.

Overall, our data suggests COVID-19 may be a highly promiscuous virus exploiting multiple mechanisms of cell entry, contributing to its severity and targeting of specific patient groups. Furthermore, using recombinant full-length spike trimer proteins coupled with cell microarray technology and flow cytometry, we have demonstrated a fast, accurate, and comprehensive approach for discovering the human cell surface targets of viruses.

Learn more about the use of this unique Cell Microarray Technology for comprehensive receptor profiling.

The paper

The Technology